Rare Stock Picks series, we're highlighting February 2025 investment picks. Click here for the list of February 2025 Buy ...

Investors should prioritize profitable companies that generate solid returns after covering all costs rather than invest in those that operate at a loss. Here, we have used the concept of accounting ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today ... While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Here are five stocks added to the Zacks Rank ... see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research?

Source (SRCE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one ...

The Nifty 50 index surged 1.15%, closing at 22,337.30, successfully reversing its previous losses. Similarly, the Sensex ...

According to the average brokerage recommendation (ABR), one should invest in Citigroup (C). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' ...

Microsoft has a wide-moat around its key businesses and faces limited competition. Click here to read why I rate MSFT stock a ...

Looking for dividend income? Explore these high-paying dividend stocks from the S&P 500 for potential returns in 2025.

Justin Zelin has given his Buy rating due to a combination of factors including Legend Biotech’s strong sales performance ... assigned a Buy rating to the stock with a $94.00 price target.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today ... While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.